Embracing Future Holdings Limited (SGX:8YY)

Singapore flag Singapore · Delayed Price · Currency is SGD
0.0390
-0.0010 (-2.50%)
At close: Jul 20, 2026
Market Cap67.60M +73.8%
Revenue (ttm)5.26M +513.2%
Net Income-3.96M
EPS-0.00
Shares Out 1.73B
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume153,900
Open0.0400
Previous Close0.0400
Day's Range0.0390 - 0.0400
52-Week Range0.0210 - 0.0920
Beta0.62
Analystsn/a
Price Targetn/a
Earnings DateAug 11, 2026

About Embracing Future Holdings

Embracing Future Holdings Limited, a precision medicine medical technology company, focuses on developing a portfolio of diagnostic solutions in Singapore, China, and Hong Kong. It operates through Cancer, Infectious Diseases, E-Sports, and Advertising segments. The company offers ClearCell FX1 System that includes Streck Cell-free DNA BCT and EDTA tubes, a fully automated device for cell retrieval that can separate wholly intact and viable circulating tumour cells, or CTCs from small amounts of blood; and CTChip FR1 biochip that isolate the CT... [Read more]

Industry Electromedical and Electrotherapeutic Apparatus
Founded 2009
Employees 16
Stock Exchange Singapore Exchange - Catalist
Ticker Symbol 8YY
Full Company Profile

Financial Performance

In 2025, Embracing Future Holdings's revenue was 5.26 million, an increase of 513.17% compared to the previous year's 858,000. Losses were -3.96 million, 15.4% more than in 2024.

Financial Statements